Assessment of quality of life in patients with type 2 diabetes mellitus before and after starting biphasic insulin aspart 30 (BIAsp 30) therapy: IMPROVE study in Japan

Current Medical Research and Opinion

Volumn 27, Issue 3, 2011, Pages 643-650

  Ishii, Hitoshi ^a   Iwase, Masanori ^b   Seino, Hiroaki ^c   Shuto, Yujin ^d   Atsumi, Yoshihito ^e  

^a TENRI HOSPITAL   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c Seino Internal Medicine Clinic   (Japan)

^d Novo Nordisk Pharma Ltd   (Japan)

^e SAISEIKAI CENTRAL HOSPITAL   (Japan)

Author keywords

Biphasic insulin aspart 30; DiabMedSat questionnaire; Qualityof life; Treatmentsatisfaction; Type 2 diabetes mellitus

Indexed keywords

INSULIN ASPART; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DIABETES MEDICATION SATISFACTION QUESTIONNAIRE; DIABETIC PATIENT; DRUG DOSE TITRATION; DRUG EFFICACY; EVENING DOSAGE; FEMALE; HUMAN; HYPOGLYCEMIA; INSULIN TREATMENT; JAPAN; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRE; SINGLE DRUG DOSE;

AGED; ALGORITHMS; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOGLYCEMIA; INSULIN; JAPAN; MALE; MIDDLE AGED; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRES; TIME FACTORS;

EID: 79951586414     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2010.551760     Document Type: Article

References (20)

1. Colman SS, Brod M, Potter LP, et al. Cross-sectional 7-year follow-up of anxiety in primary care patients. Depress. Anxiety 2004;19:105-11 (Pubitemid 38387602)
2. Nathan DM, Buse JB, Davidson MB, et al.; American Diabetes Association; European Association for Study of Diabetes. Medical management of hyper-glycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009;32:193-203
3. The 3rd International DAWN Summit: from research and practice. Pract Diabetes Int 2006;23:313-16
4. Hirose T. Biphasic insulin analogue - profiles and clinical application in comparison with other pre-mixed insulin. [Shinryō] Diagnosis and Treatment, 2006; 94:2349-53
5. Kawamori R, Kasuga M, Kadowaki T, et al. Safety and efficacy of biphasic insulin aspart 30 in Japanese type-2 diabetes - IMPROVE Study JAPAN. Jpn Pharmacol Ther 2009;37:233-41
6. Iwamoto Y, Atsumi Y, Awata T, et al. Questionnaire Concerning Physician Resource Utilization of Biphasic Insulin Aspart 30 (BIAsp 30) in patients with type 2 Diabetes (T2D) - IMPROVE study in Japan. Jpn J Diabet Mast Clin 2009; submitted for publication
7. Good Postmarketing Study Practice (GPSP). Ministry of Health, Labour and Welfare [MHLW] Ministerial Ordinance No.171. Dec 2004.
8. Good Vigilance Practice (GVP). Ministry of Health, Labour and Welfare [MHLW] Ministerial Ordinance No.135. Sep 2004
9. Brod M, Skovlund SE, Wittrup-Jensen KU. Measuring the impact of diabetes through patient report of treatment satisfaction, productivity and symptom experience. Qual Life Res 2006;15:481-91
10. Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation health related quality of life measures: Literature review and proposed guidelines. J. Clin Epidemiol 1993;46:1417-32 (Pubitemid 24017263)
11. Ikegami N, Fukuhara S, Shimotsuma A, et al. Clinical Handbook for QOL Evaluation. Tokyo, Igakushoin, 2001:8-13
12. Ishii H, Shuto Y, Okuyama S. Development of the Japanese Version of the Diabetes Medication Satisfaction Questionnaire(Diab-MedSat). J Jpn Diabetes Soc 2009;52:527-35
13. Brod M, Kongsø JH, Lessard S, et al. Psychological insulin resistance: patient beliefs and implications for diabetes management. Qual Life Res 2009; 18:23-32
14. Nakar S, Yitzhaki G, Rosenberg R, et al. Transition to insulin in type 2 diabetes: family physicians' misconception of patients' fears contributes to existing barriers. J Diabetes Complications 2007;21:220-6 (Pubitemid 47002315)
15. The DCCT Research Group (1991) Epidemiology of severe hypoglyce-mia in the diabetes control and complications trials. Am J Med 1991; 90:450-9
16. Ishii H, Furuya M, Iburi T, et al. Insulin therapy related QOL at night (ITR-QOLN). J Jpn Diabetes Soc 2008;51:601-8
17. Ishii H, Yamamoto Y, Ohashi Y. Quality of life in insulin users measured by ITR-QOL. J Jpn Diabetes Soc 2001;44:17-22 (Pubitemid 32172474)
18. Yamada S, Tamada T, Watanabe M, et al. Comparison of biphasic insulin aspart 30/70 and premixed human insulin 30/70: glycemic control and quality-of-life in insulin-na?̈ve type 2 diabetic patients. Clin Pract 2007; 26:58-64
19. Kobayashi T, Yamazaki K, Kanetsuka A. Japan Diabetes Clinical Data Management Study Group (2006) CoDiC(R): Surveillance of clinical management of diabetes in Japan (2nd report). Jpn J Diabetes Mast Clin 2006;4:751-5
20. Odawara M, Saito Y, Hayashi Y, et al. DAWN Japan Study Group. DAWN Japan study 1-5. J Jpn Diabetes Soc 2006;49(Suppl):S187